检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈韵名[1] 邓烈华[1] 张媛莉[1] 李娟[1] 姚华国[1]
机构地区:[1]广东医学院附属医院重症医学科,广东湛江524001
出 处:《重庆医学》2015年第31期4355-4357,4360,共4页Chongqing medicine
基 金:广东医学院青年科研基金资助项目(Q2012030)
摘 要:目的探讨D-乳酸跨肺梯度在快速诊断肺炎及疗效评估中的作用。方法选择入住重症监护病房(ICU)患者为研究对象,患者分肺炎组(n=46)及非肺炎组(n=28),比较两组患者在治疗前、治疗后第3天、第7天D-乳酸跨肺梯度的差异,分析D-乳酸跨肺梯度诊断肺炎的特异度和灵敏度,分析其与肺损伤评分(LIS)、临床肺部感染评分(CPIS)、氧合指数和血清降钙素原(PCT)水平的关系。结果与非肺炎组相比,肺炎组D-乳酸跨肺梯度显著升高[(163.84±10.72)ng/mL vs.(30.33±7.25)ng/mL,P<0.01)],以106.11ng/mL为截断值,D-乳酸跨肺梯度诊断肺炎的灵敏度为90.7%,特异度为75.5%;D-乳酸跨肺梯度与LIS及CPIS存在直线相关关系(分别为r=0.554,P<0.01;r=0.543,P<0.01)。结论 D-乳酸跨肺梯度与肺部感染密切相关,有望成为快速诊断肺炎及判断疗效的指标。Objective To study the role of D-lactate gradient across the lung in the rapid diagnosis of pneumonia and evaluation of therapeutic efficacy. Methods Patients were divided into pneumonia group (n= 46) and non-pneumonia group (n=28) in ICU. D-lactate gradient across the lung were calculated by the difference between hrterial and mixed-venous D-lactate concentrations before the treatment.after 3 and 7 days of treatment. Serum procalcitonin (PCT), Oxygenation index, the lung injury score (LIS) and clinical pulmonary infection score(CPIS) were recorded at the same time. Results The mean D-lactate gradient across the lung in pneumonia group was significantly higher than that in non-pneumonia group [(163.84 ± 10.72) ng/mL vs. (30. 33 ± 7.25) ng/mL, P〈0.01) -before treatment. Using a cut-off value of 106. 11 ng/mL,D-lactate gradient across the lung's sensitivity for diagnosis pneumonia was 90. 7 % and its' specificity was 75.5 %. D-lactate gradient across the lung correlated with LIS(r= 0. 554, P〈0. 01) and CPIS(r=O. 543,P〈0. 01). Conclusion D-lactate gradient across the lung correlates with lung injury and pulmonary infection positively and may be a potential biomarker for rapid diagnosis of pneumonia.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.43